Cell-derived extracellular vesicle mediated epigenetic silencing of HIV in the brain
Cell-derived extracellular vesicle mediated epigenetic silencing of HIV in the brain
批准号:
10748545
负责人:
Fatah Kashanchi
金额:
$63.14万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-02 至 2028-05-31
关键词:
Acquired Immunodeficiency SyndromeAdherenceAnti-Retroviral AgentsAstrocytesBlood VesselsBrainCCR5 geneCD34 geneCXCR4 ReceptorsCell LineCell modelCellsCentral Nervous SystemDNA MethylationDeath RateDiseaseDrug TargetingDrug resistanceEngineeringEnzymesEpigenetic ProcessGenerationsGenesGenetic TranscriptionGenomeHIVHIV Envelope Protein gp120HIV InfectionsHIV-1Highly Active Antiretroviral TherapyHumanImmuneImmune systemIn VitroIndividualInfectionIntravenousLentivirusLife ExpectancyMacrophageMediatingMeningealMethodologyMethodsMicrogliaModalityMorbidity - disease rateMusNeurosphereNuclear Pore ComplexOpportunistic InfectionsPathway interactionsPatientsPersonsPharmacotherapyProvirus IntegrationProvirusesRNARecombinantsRepressionShockSiteTechniquesTestingTherapeuticViralVirusVirus DiseasesZinc Fingersantiretroviral therapycostepigenetic regulationepigenetic silencingextracellular vesicleshuman diseaseimprovedin vivoinduced pluripotent stem cellinnovationmonocytemouse modelnerve stem cellneuroAIDSnovelparticlepromoterreceptorside effectsmall hairpin RNAtherapeutic RNA
中文摘要
项目摘要
细胞外囊泡介导的脑内HIV的表观遗传沉默
人类免疫缺陷病毒1型(HIV)是一种慢病毒,可导致持续性病毒感染和
导致免疫调节细胞死亡。通过免疫系统清除艾滋病毒感染是
低效,将前病毒整合到宿主细胞的基因组中提供了一种长期
持续性和潜伏期,需要终生抗逆转录病毒治疗。此外,这一点正变得越来越明显
HIV感染的单核/巨噬细胞是HIV-1在中枢神经系统的避难所
(中枢神经系统),在那里它们似乎有助于艾滋病毒相关的神经疾病(手)。一个
可特异性靶向并在表观上沉默感染病毒内的艾滋病毒前病毒的方法学
大脑中的小胶质细胞可能是开发功能性治愈方法的一种手段,并可能是一种
手部的治疗。我们最近开发了一种锌指表观遗传抑制因子,它可以在表观遗传上
通过静脉注射细胞外小泡(EVS)使HIV在大脑中静默。我们在这里求婚
为了对比这种重组锌指方法EV方法和小发夹状RNA(ShRNA)EV方法
方法,这也是针对LTR,以表观遗传沉默艾滋病毒转录。的前提是
这项提议是,细胞衍生的电动汽车可以用来传递新型的抗艾滋病毒锌指或LTR
靶向转录调控shRNA到大脑,并在表观遗传上沉默艾滋病毒。我们建议3个
目的是验证细胞衍生受体靶向含有抗HIV锌的EV的假设
Finger和LTR指导的shRNA,两者都是利用内源性细胞的HIV转录调节因子
表观遗传沉默机制(3-5,14),可在体内系统传播并稳定沉默HIV
抄写。我们将在体内使用模块化的胞外囊泡(EV)传递来验证这一假设
方法,通过神经干细胞(NSC)将被工程,使其结构性地生成
抗HIV EVS能够细胞导向稳定的表观遗传沉默HIV。如果成功,则该方法
这里概述的可能不仅导致HIV在大脑中的表观遗传沉默,而且还有助于迎来
可以与内源性细胞无缝操作的新一代EV-RNA疗法
针对基因转录的表观遗传调控的机制。
英文摘要
Project Summary
Extracellular vesicle mediated epigenetic silencing of HIV in the brain
Human Immunodeficiency Virus type 1 (HIV) is a lentivirus that causes a persistent viral infection and
results in the demise of immune regulatory cells. Clearance of HIV infection by the immune system is
inefficient, and integration of provirus into the genome of host cells provides a means for long-term
persistence and latency which require lifelong anti-retroviral therapy. Moreover, it is becoming apparent
that HIV-infected monocyte/macrophages represent a sanctuary for HIV-1 in central nervous system
(CNS), where they appear to contribute to HIV-associated neurological disorders (HAND). A
methodology that can specifically target and epigenetically silence HIV provirus within virus infected
microglial cells in the brain could be one means by which to develop a functional cure and possibly a
treatment for HAND. We recently developed a zinc finger epigenetic repressor that can epigenetically
silence HIV in the brain when delivered by extracellular vesicles (EVs) intravenously. We propose here
to contrast this recombinant zinc finger approach EV approach with a small hairpin RNA (shRNA) EV
approach, which is also targeted to the LTR to epigenetically silence HIV transcription. The premise of
this proposal is that cellular-derived EVs can be used to deliver novel anti-HIV zinc finger or LTR
targeted transcriptional modulating shRNAs to the brain and epigenetically silence HIV. We propose 3
aims here to test the hypothesis that cellular derived receptor targeted EVs containing anti-HIV zinc
finger and the LTR directed shRNA, both regulators of HIV transcription that utilize endogenous cellular
epigenetic silencing mechanisms (3-5, 14), can spread systemically in vivo and stably silence HIV
transcription. We will test this hypothesis here in vivo using a modular extracellular vesicle (EV) delivery
approach, whereby by neural stem cells (NSC) will be engineered such that they constitutively generate
anti-HIV EVs capable of cell directed stable epigenetic silencing of HIV. If successful the approach
outlined here may not only result in the epigenetic silencing of HIV in the brain but also help usher in a
new generation of EV-RNA therapies that can operate seamlessly with endogenous cellular
mechanisms to target epigenetic regulation of gene transcription.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
American Society for Intercellular Communication (ASIC)
-
批准号:10753704
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2023
-
负责人:Fatah Kashanchi
-
依托单位:
American Society for Intercellular Communication (ASIC)
-
批准号:10539845
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2022
-
负责人:Fatah Kashanchi
-
依托单位:
Effect on CBD on Exosome release from CNS infected cells
-
批准号:9884894
-
项目类别:
-
资助金额:$21.1万
-
财政年份:2020
-
负责人:Fatah Kashanchi
-
依托单位:
Role of extracellular vesicles in methamphetamine and HIV induced neurotoxicity
-
批准号:9929090
-
项目类别:
-
资助金额:$0.43万
-
财政年份:2018
-
负责人:Fatah Kashanchi
-
依托单位:
A radiation-induced cellular stress activates HIV and induces killing of infected cells
-
批准号:9326140
-
项目类别:
-
资助金额:$22.8万
-
财政年份:2016
-
负责人:Fatah Kashanchi
-
依托单位:
HIV neuropathogenesis related to exosomes containing HIV non-coding RNAs
-
批准号:9136536
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2016
-
负责人:Fatah Kashanchi
-
依托单位:
HIV neuropathogenesis related to exosomes containing HIV non-coding RNAs
-
批准号:9893927
-
项目类别:
-
资助金额:$37.7万
-
财政年份:2016
-
负责人:Fatah Kashanchi
-
依托单位:
A radiation-induced cellular stress activates HIV and induces killing of infected cells
-
批准号:9212863
-
项目类别:
-
资助金额:$19.0万
-
财政年份:2016
-
负责人:Fatah Kashanchi
-
依托单位:
Effect of novel cdk9 inhibitor on HIV transcription
-
批准号:8793029
-
项目类别:
-
资助金额:$20.68万
-
财政年份:2014
-
负责人:Fatah Kashanchi
-
依托单位:
Effect of novel cdk9 inhibitor on HIV transcription
-
批准号:8894397
-
项目类别:
-
资助金额:$22.09万
-
财政年份:2014
-
负责人:Fatah Kashanchi
-
依托单位:
Nanotrap particle-based assay to quantify HIV-1 in latently-infected T cells
-
批准号:8874895
-
项目类别:
-
资助金额:$22.29万
-
财政年份:2014
-
负责人:Fatah Kashanchi
-
依托单位:
Treatment of Tat neurotoxicity through the use of Gsk3-b inhibitors
-
批准号:8151114
-
项目类别:
-
资助金额:$18.26万
-
财政年份:2010
-
负责人:Fatah Kashanchi
-
依托单位:
Basic Science
-
批准号:7930044
-
项目类别:
-
资助金额:$15.62万
-
财政年份:2010
-
负责人:Fatah Kashanchi
-
依托单位:
Treatment of Tat neurotoxicity through the use of Gsk3-b inhibitors
-
批准号:8071852
-
项目类别:
-
资助金额:$22.36万
-
财政年份:2010
-
负责人:Fatah Kashanchi
-
依托单位:
Effect of chromatin remodelers/modifiers on HIV-1 Tat activated transcription
-
批准号:7757069
-
项目类别:
-
资助金额:$25.06万
-
财政年份:2009
-
负责人:Fatah Kashanchi
-
依托单位:
HIV-1 TAR derived miRNA: Implications for Latency and Pathogenesis
-
批准号:7685780
-
项目类别:
-
资助金额:$23.45万
-
财政年份:2009
-
负责人:Fatah Kashanchi
-
依托单位:
Effect of chromatin remodelers/modifiers on HIV-1 Tat activated transcription
-
批准号:8082018
-
项目类别:
-
资助金额:$18.19万
-
财政年份:2009
-
负责人:Fatah Kashanchi
-
依托单位:
HIV-1 TAR derived miRNA: Implications for Latency and Pathogenesis
-
批准号:7842609
-
项目类别:
-
资助金额:$16.6万
-
财政年份:2009
-
负责人:Fatah Kashanchi
-
依托单位:
Mechanism of activated transcription in the new HTLV-3 virus
-
批准号:7500279
-
项目类别:
-
资助金额:$19.09万
-
财政年份:2007
-
负责人:Fatah Kashanchi
-
依托单位:
Mechanism of activated transcription in the new HTLV-3 virus
-
批准号:7189157
-
项目类别:
-
资助金额:$23.26万
-
财政年份:2007
-
负责人:Fatah Kashanchi
-
依托单位:
海外基金